SMTL ID : 6tfz.2 (1 other biounit)

Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 19

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x N7B: ~{N}-[2-(2-hydroxyethyloxy)-5-[4-[[1-(phenylmethyl)indazol-5-yl]amino]-7~{H}-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]propanamide(Covalent)

N7B.1: 24 residues within 4Å: Chain A: L.29, G.30, S.31, V.37, A.54, K.56, M.77, C.86, L.88, L.99, M.101, Q.102, L.103, M.104, G.107, C.108, D.111, R.152, L.155, T.165, D.166, F.167, A.170 Ligands: SO4.3 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:L.29, A:L.29, A:V.37, A:V.37, A:V.37, A:R.152, A:A.170 Hydrogen bonds: A:K.56, A:M.104, A:M.104, A:R.152, A:D.166, A:D.166 Water bridges: A:C.108, A:D.111

3 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 3 residues within 4Å: Chain A: K.157, T.158, H.161 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:T.158 Water bridges: A:K.157, A:K.157 Salt bridges: A:K.157, A:H.161 SO4.3: 8 residues within 4Å: Chain A: G.32, A.33, F.34, G.35, K.56, R.152, D.166 Ligands: N7B.1 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:A.33, A:F.34, A:G.35, A:G.35 Salt bridges: A:K.56, A:R.152 SO4.4: 2 residues within 4Å: Chain A: R.114, K.224 5 PLIP interactions: 5 interactions with chain A Water bridges: A:R.114, A:R.114, A:K.224 Salt bridges: A:R.114, A:K.224

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.5: 3 residues within 4Å: Chain A: L.14, D.81, R.87 1 PLIP interactions: 1 interactions with chain A Water bridges: A:D.81

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lategahn, J. et al., Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design Approach. J.Med.Chem. (2020)

Release Date

2020-09-30

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Epidermal growth factor receptor

Related Entries With Identical Sequence